GLP-1 Insurance & Coverage

What insurance typically covers for GLP-1 weight-loss treatment, how HSA/FSA fits in, and how to handle a denial.

Last updated: Sourcing method: Editorial slot — to be filledReviewed by: Medical reviewer slot — to be assigned

Does insurance cover GLP-1 medications for weight loss?

Coverage is inconsistent. Most commercial plans cover GLP-1s for type 2 diabetes (Ozempic, Mounjaro) but far fewer cover them for obesity (Wegovy, Zepbound), which is why many people seeking weight loss pay cash. Coverage that does exist usually requires prior authorization. HSA and FSA funds can generally be used regardless of whether a plan covers the drug. Always verify with your own insurer, because coverage depends on your specific plan.

Insurance is often the deciding factor in what a GLP-1 program costs you. The catch is that coverage for weight loss is far patchier than coverage for diabetes, and the rules change frequently. This guide explains the coverage landscape, the obesity-vs-diabetes distinction that drives most denials, how prior authorization and appeals work, and what to ask a clinic before you start.

The coverage landscape

There is no single answer to “is it covered,” because it depends on your plan and why the drug is prescribed. In broad strokes:

  • Commercial (employer / marketplace) plans: Frequently cover GLP-1s for type 2 diabetes; cover them for obesity much less often, and usually with prior authorization when they do.
  • Medicare: Has not historically covered anti-obesity medications. As of July 1, 2026, a Part D GLP-1 Bridge program is live, providing roughly a $50 monthly copay for certain eligible beneficiaries. Verify your own eligibility directly with Medicare.
  • Medicaid: Coverage for obesity varies by state; verify your state's current formulary.
  • Compounded GLP-1s: Generally not covered by insurance at all, which is why cash-pay compounded programs exist.
GLP-1 coverage at a glance (2026, verify against your own plan)
PayerDiabetes indicationObesity indication
Commercial plansOften covered (prior auth common)Covered less often; prior auth
Medicare Part DCovered for diabetesGLP-1 Bridge program live as of July 1, 2026 (~$50/mo copay, certain beneficiaries)
MedicaidVaries by stateVaries by state; verify your state's formulary
Compounded (any payer)Generally not coveredGenerally not covered

Obesity vs. diabetes: why the indication matters

The same molecule is sold under different brand names for different approved uses. Semaglutide is Ozempic for diabetes and Wegovy for weight loss. Tirzepatide is Mounjaro for diabetes and Zepbound for weight loss. Insurers key their coverage to the approved indication, so the diabetes-labeled versions are more widely covered than the weight-loss ones. This is the single most common reason a weight-loss GLP-1 claim is denied even when the drug itself is on the formulary.

What is prior authorization for a GLP-1?

Prior authorization is your insurer's requirement that your provider justify the prescription before the plan will pay. For GLP-1s that often means documenting your BMI (typically 30+, or 27+ with a weight-related condition), relevant diagnoses, and sometimes prior attempts at weight management. If prior auth is denied, you generally have the right to appeal with additional documentation from your provider. Ask your clinic whether they handle prior authorizations and appeals, because not all cash-pay telehealth clinics do.

If you are denied: appeals

A denial is not always the end. Most plans allow an internal appeal, and many allow an external review after that. A strong appeal usually leans on your provider documenting medical necessity: BMI, comorbidities such as hypertension or high cholesterol, and clinical rationale. Because appeals are plan-specific and time-sensitive, work with a provider or clinic that will supply the paperwork, and confirm your plan's deadlines. This is a decision to make with a licensed provider and your insurer, not one to navigate on price alone.

What to ask a clinic about insurance

  • Do you bill insurance, or is this cash-pay only?
  • Do you prescribe brand (which insurance might cover) or compounded (which it usually won’t)?
  • Do you handle prior authorizations and appeals, or is that on me?
  • Are labs and consults billable to my insurance separately?
  • Is the medication HSA/FSA eligible through your program?

A clinic that is upfront about being cash-pay is being honest, and many good ones are. The concern is a clinic that is vague about what insurance will and won’t do. Clear, honest disclosure is part of what we reward in our grading methodology. For the full cost picture, including cash pricing, see our cost guide, or compare graded clinics.

This guide is informational and not medical, insurance, or financial advice. Coverage rules change and depend entirely on your specific plan. Verify current coverage, prior-authorization requirements, and appeal deadlines directly with your insurer, and discuss treatment decisions with a licensed provider.

Frequently Asked Questions

Can I use my HSA or FSA to pay for GLP-1 medication?

In most cases, yes. GLP-1 therapy prescribed by a licensed provider is HSA and FSA eligible at most providers, whether the medication is brand or compounded. Because rules and documentation requirements vary, confirm eligibility with your HSA/FSA administrator and keep your prescription and receipts.

Why do so many GLP-1 clinics require cash payment?

Because commercial insurance often does not cover GLP-1s for weight loss, and compounded versions are generally not covered at all. Many telehealth clinics therefore run a cash-pay model, frequently using compounded semaglutide or tirzepatide at $200-$500 per month. This sidesteps insurance entirely, which is simpler for the clinic but means the full cost falls on you.

What is the difference between coverage for obesity and diabetes?

It is the FDA-approved indication on the prescription. Ozempic and Mounjaro are approved for type 2 diabetes and are more widely covered. Wegovy and Zepbound are approved for weight loss (obesity) and are covered less often. Some providers prescribe the diabetes-labeled version off-label for weight loss to access better coverage, but that is a clinical and insurance decision to discuss with your provider.

Does Medicare or Medicaid cover GLP-1s for weight loss?

Historically Medicare did not cover medications for obesity. As of July 1, 2026, a Medicare Part D GLP-1 Bridge program is live, providing roughly a $50 monthly copay for certain eligible beneficiaries. Medicaid coverage for obesity varies by state; verify your state's current formulary. Verify current Medicare and your state's Medicaid coverage before assuming either applies.